Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07508306
What this trial is testing

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Who this might be right for
Sentinel Lymph Node Biopsy (SLNB)Early Stage Ovarian Tumors
Faculty of Medicine of Tunis 30
Not applicableLooking for participantsNCT07539038
What this trial is testing

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Who this might be right for
Breast Cancer
Centro di Riferimento Oncologico - Aviano 44
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Not applicableUnknownNCT06733311
What this trial is testing

A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.

Who this might be right for
Early-Stage Lung CancerNSCLCPulmonary Nodule
Beijing Chao Yang Hospital 480
Testing effectiveness (Phase 2)UnknownNCT04881929
What this trial is testing

Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 30
Testing effectiveness (Phase 2)Looking for participantsNCT06902272
What this trial is testing

CtDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Miami 30
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Large-scale testing (Phase 3)UnknownNCT01014130
What this trial is testing

Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Trans Tasman Radiation Oncology Group 101
Testing effectiveness (Phase 2)UnknownNCT02605811
What this trial is testing

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerMetastatic Carcinoma
Guangzhou Medical University 426
Large-scale testing (Phase 3)Study completedNCT01530607
What this trial is testing

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 416
Post-approval studies (Phase 4)Study completedNCT03664687
What this trial is testing

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)

Who this might be right for
Early-stage Breast Cancer
Ottawa Hospital Research Institute 211
Not applicableLooking for participantsNCT07723209
What this trial is testing

Radiation After No Axillary Nodal Sampling

Who this might be right for
Early-stage Breast CancerInvasive Ductal Carcinoma of Female Breast
NYU Langone Health 105
Testing effectiveness (Phase 2)Study completedNCT00191763
What this trial is testing

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung Cancer
Eli Lilly and Company 52
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Not applicableStudy completedNCT03486821
What this trial is testing

Ultra-hypofractionated Radiation in Prostate Cancer

Who this might be right for
Early Stage Prostate Cancer
University of Kansas Medical Center 13
Not applicableStudy completedNCT01271738
What this trial is testing

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+4 more
Emory University 79
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02750358
What this trial is testing

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Who this might be right for
Breast CancerEarly StageTriple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02095873
What this trial is testing

Healthy Aging Through Functional Food

Who this might be right for
Glucose IntoleranceAortic StiffnessVasodilation
University of Warwick 32
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Next Page